FDA approves Endo International’s testosterone drugReuters(Reuters) – Endo International Plc said the U.S. Food and Drug Administration approved its thrice-rejected testosterone replacement therapy, Aveed, to treat male hypogonadism. The company’s shares rose 4.6 percent in premarket trading. The regulator …U.S. FDA Approves AVEED™ (Testosterone Undecanoate) Injectable …MarketWatchFDA Approves Endo U.S. Testosterone Replacement TherapyPharmaceutical Processingall 7 news articles …read more
Via: Google USA
FDA approves Endo International's testosterone drug - Reuters
Real Estate of Cebu
